These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 37312022)
41. Establishment of a Nomogram by Integrating Molecular Markers and Tumor-Node-Metastasis Staging System for Predicting the Prognosis of Hepatocellular Carcinoma. Huang XT; Chen LH; Huang CS; Li JH; Cai JP; Chen W; Yin XY Dig Surg; 2019; 36(5):426-432. PubMed ID: 30481744 [TBL] [Abstract][Full Text] [Related]
42. Development and validation of a nomogram for predicting the cancer-specific survival of fibrolamellar hepatocellular carcinoma patients. Hu J; Wang Y; Deng L; Yu H; Chen K; Bao W; Chen K; Chen G Updates Surg; 2022 Oct; 74(5):1589-1599. PubMed ID: 35713784 [TBL] [Abstract][Full Text] [Related]
43. Development and validation of a nomogram for survival prediction in hepatocellular carcinoma after partial hepatectomy. Lu Y; Ren S; Jiang J BMC Surg; 2023 Jan; 23(1):27. PubMed ID: 36717904 [TBL] [Abstract][Full Text] [Related]
44. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis. Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703 [TBL] [Abstract][Full Text] [Related]
45. New nomogram predicts the recurrence of hepatocellular carcinoma in patients with negative preoperative serum AFP subjected to curative resection. Gan W; Huang JL; Zhang MX; Fu YP; Yi Y; Jing CY; Fan J; Zhou J; Qiu SJ J Surg Oncol; 2018 Jun; 117(7):1540-1547. PubMed ID: 29572833 [TBL] [Abstract][Full Text] [Related]
46. Ascites and alpha-fetoprotein improve prognostic performance of Barcelona Clinic Liver Cancer staging. Gomaa AI; Al-Khatib A; Abdel-Razek W; Hashim MS; Waked I World J Gastroenterol; 2015 May; 21(18):5654-62. PubMed ID: 25987792 [TBL] [Abstract][Full Text] [Related]
47. The prognostic significance of inflammation-immunity-nutrition score on postoperative survival and recurrence in hepatocellular carcinoma patients. Liang Y; Zhang Z; Zhong D; Lai C; Dai Z; Zou H; Feng T; Shang J; Shi Y; Huang X Front Oncol; 2022; 12():913731. PubMed ID: 36016629 [TBL] [Abstract][Full Text] [Related]
48. Body Composition Changes in Hepatocellular Carcinoma: Prediction of Survival to Transcatheter Arterial Chemoembolization in Combination With Clinical Prognostic Factors. Zheng X; Cao F; Qian L; Dong J Cancer Control; 2021; 28():10732748211038445. PubMed ID: 34569304 [TBL] [Abstract][Full Text] [Related]
49. Identification and characterization of a 25-lncRNA prognostic signature for early recurrence in hepatocellular carcinoma. Fu Y; Wei X; Han Q; Le J; Ma Y; Lin X; Xu Y; Liu N; Wang X; Kong X; Gu J; Tong Y; Wu H BMC Cancer; 2021 Oct; 21(1):1165. PubMed ID: 34717566 [TBL] [Abstract][Full Text] [Related]
50. A nomogram to predict prognosis after surgery for young patients with hepatocellular carcinoma. Li X; Bi X; Zhao J; Li Z; Zhou J; Huang Z; Zhang Y; Zhao H; Cai J Transl Cancer Res; 2021 Apr; 10(4):1773-1786. PubMed ID: 35116501 [TBL] [Abstract][Full Text] [Related]
51. Prediction of prognosis of patients with hepatocellular carcinoma based on immune-related score. Song XQ; Li RJ; Zhang S Asian J Surg; 2024 Jan; 47(1):310-319. PubMed ID: 37673742 [TBL] [Abstract][Full Text] [Related]
52. Novel Nomograms Based on Gamma-Glutamyl Transpeptidase-to-Lymphocyte Ratio Predict Prognosis of Hepatocellular Carcinoma Patients After Hepatectomy. Ma C; Cao Y; Zhang G; Qiu J; Zhou Y; Wang P; Wang S; Yan D; Ma D; Jiang C; Wang Z J Hepatocell Carcinoma; 2023; 10():217-230. PubMed ID: 36798739 [TBL] [Abstract][Full Text] [Related]
53. Prognostic nomogram for hepatocellular carcinoma patients after transarterial chemoembolization based on des-γ-carboxy prothrombin reactivity and modified Response Evaluation Criteria in Solid Tumors. Zhao SM; Qiu LW; Zhao H; Gu WW; Yang XH; Gu ZX; Shi RF; Ni CF J Cancer Res Ther; 2021 Jul; 17(3):707-714. PubMed ID: 34269303 [TBL] [Abstract][Full Text] [Related]
54. Development and validation of prognostic nomograms in patients with hepatocellular carcinoma: a population-based study. Zang Y; Long P; Wang M; Huang S; Chen C Future Oncol; 2021 Dec; 17(36):5053-5066. PubMed ID: 34676798 [No Abstract] [Full Text] [Related]
55. Construction and validation of prognostic nomograms for elderly patients with metastatic non-small cell lung cancer. Sun H; Liu M; Yang X; Ren Y; Dai H; Wang C Clin Respir J; 2022 May; 16(5):380-393. PubMed ID: 35514033 [TBL] [Abstract][Full Text] [Related]
56. Development and Assessment of Novel Predictive Nomograms Based on APRI for Hepatitis B Virus-associated Small Solitary Hepatocellular Carcinoma with Stereotactic Body Radiotherapy. Lai L; Su T; Liang Z; Lu Y; Hou E; Lian Z; Gao H; Zhu X J Cancer; 2020; 11(22):6642-6652. PubMed ID: 33046985 [No Abstract] [Full Text] [Related]
57. A SEER-based nomogram accurately predicts prognosis in Ewing's sarcoma. Zhan H; Mo F; Zhu M; Xu X; Zhang B; Liu H; Dai M Sci Rep; 2021 Nov; 11(1):22723. PubMed ID: 34811459 [TBL] [Abstract][Full Text] [Related]
58. Validation of the six-and-twelve criteria among patients with hepatocellular carcinoma and performance score 1 receiving transarterial chemoembolization. Wang ZX; Li J; Wang EX; Xia DD; Bai W; Wang QH; Yuan J; Li XM; Niu J; Yin ZX; Xia JL; Fan DM; Han GH World J Gastroenterol; 2020 Apr; 26(15):1805-1819. PubMed ID: 32351295 [TBL] [Abstract][Full Text] [Related]
59. A nomogram to predict microvascular invasion in early hepatocellular carcinoma. Li H; Li T; Hu J; Liu J J Cancer Res Ther; 2021 Jul; 17(3):652-657. PubMed ID: 34269295 [TBL] [Abstract][Full Text] [Related]
60. A practical nomogram and risk stratification system predicting the cancer-specific survival for patients with early hepatocellular carcinoma. Yan B; Su BB; Bai DS; Qian JJ; Zhang C; Jin SJ; Jiang GQ Cancer Med; 2021 Jan; 10(2):496-506. PubMed ID: 33280269 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]